Eli Lilly has reported Phase 3 results showing that its investigational oral GLP-1 therapy...
Author - Abby Davey
Sanofi to acquire Dynavax, expanding adult vaccine portfolio
Sanofi has agreed to acquire Dynavax Technologies Corporation, adding an approved adult hepatitis B...
University of Stirling Uses Immersive Pandemic Simulation to...
The University of Stirling has introduced an immersive pandemic simulation designed to prepare...
GSK Announces Promising Blood Cancer Data at ASH 2025 –...
GSK is set to present new data from its haematology portfolio at the American Society of Hematology...
Clinigen to Acquire SSI Strategy, Strengthening Biotech...
Clinigen, a global leader in accelerating patient access to critical medicines, has announced a...
Hikma and Celltrion deepen biosimilar partnership to broaden...
Hikma Pharmaceuticals PLC and Celltrion Healthcare Co., Ltd. have announced a new phase in their...
MaxCyte and Ori Biotech Partner to Enhance Cell Therapy...
MaxCyte has entered into a collaboration with Ori Biotech to improve manufacturing efficiencies and...
US-UK Tech Pact to Accelerate Drug Discovery & Create Jobs
The United Kingdom and United States have formalised a Tech Prosperity Deal aimed at speeding up...
UK biotech secures £1.23 billion investment in first half of...
The BioIndustry Association (BIA) has published new data showing that the UK’s life sciences sector...
New 36-Month Efficacy and Safety Data for Leqembi (Lecanemab)...
Eisai has announced new 36-month (3-year) efficacy and safety results from its Phase 3 Clarity AD...